{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:31:43Z","timestamp":1789781503473,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"PRODEP- SEP Mexico","award":["UDG-PTC-1433"],"award-info":[{"award-number":["UDG-PTC-1433"]}]},{"name":"the University of Guadalajara - Strengthening Research and Postgraduate 2018","award":["244159"],"award-info":[{"award-number":["244159"]}]},{"name":"PROFIDES-SEP for research networks, 2017","award":["511-6\/18-11870"],"award-info":[{"award-number":["511-6\/18-11870"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10238-019-00569-4","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T02:02:49Z","timestamp":1564365769000},"page":"439-447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["TNFA -308G>A and -238G>A polymorphisms and risk to systemic sclerosis: impact on TNF-\u03b1 serum levels, TNFA mRNA expression, and autoantibodies"],"prefix":"10.1007","volume":"19","author":[{"given":"Jos\u00e9 Alvaro","family":"Lomel\u00ed-Nieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Francisco","family":"Mu\u00f1oz-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Johana","family":"Ba\u00f1os-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eduardo","family":"Navarro-Zarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Guadalupe","family":"Ram\u00edrez-Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Ernesto","family":"S\u00e1nchez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Carolina","family":"Machado-Sulbaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isela","family":"Parra-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Garc\u00eda-Chagoll\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-1811","authenticated-orcid":false,"given":"Jorge","family":"Hern\u00e1ndez-Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"key":"569_CR1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jbspin.2014.10.010","volume":"82","author":"M Elhai","year":"2015","unstructured":"Elhai M, Avouac J, Kahan A, Allanore Y. Systemic sclerosis: recent insights. Jt Bone Spine Rev Rhum. 2015;82:148\u201353.","journal-title":"Jt Bone Spine Rev Rhum"},{"key":"569_CR2","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/annrheumdis-2015-207477","volume":"75","author":"NC Brembilla","year":"2016","unstructured":"Brembilla NC, Dufour AM, Alvarez M, et al. IL-22 capacitates dermal fibroblast responses to TNF in scleroderma. Ann Rheum Dis. 2016;75:1697\u2013705.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 6","key":"569_CR3","doi-asserted-by":"crossref","first-page":"s58","DOI":"10.7861\/clinmedicine.15-6-s58","volume":"15","author":"CP Denton","year":"2015","unstructured":"Denton CP. Advances in pathogenesis and treatment of systemic sclerosis. Clin Med Lond Engl. 2015;15(Suppl 6):s58\u201363.","journal-title":"Clin Med Lond Engl"},{"key":"569_CR4","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1136\/annrheumdis-2013-203618","volume":"73","author":"K Andr\u00e9asson","year":"2014","unstructured":"Andr\u00e9asson K, Saxne T, Bergknut C, Hesselstrand R, Englund M. Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria. Ann Rheum Dis. 2014;73:1788\u201392.","journal-title":"Ann Rheum Dis"},{"key":"569_CR5","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, et al. Systemic sclerosis. Nat Rev Dis Primer. 2015;1:15002.","journal-title":"Nat Rev Dis Primer"},{"key":"569_CR6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s10067-018-4182-3","volume":"37","author":"JG Royle","year":"2018","unstructured":"Royle JG, Lanyon PC, Grainge MJ, Abhishek A, Pearce FA. The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Clin Rheumatol. 2018;37:2103\u201311.","journal-title":"Clin Rheumatol"},{"key":"569_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3899\/jrheum.100951","volume":"86","author":"I Pel\u00e1ez-Ballestas","year":"2011","unstructured":"Pel\u00e1ez-Ballestas I, Sanin LH, Moreno-Montoya J, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl. 2011;86:3\u20138.","journal-title":"J Rheumatol Suppl"},{"key":"569_CR8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/acr.20487","volume":"63","author":"SM Bongi","year":"2011","unstructured":"Bongi SM, Del Rosso A, Passalacqua M, Miccio S, Cerinic MM. Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res. 2011;63:1134\u201341.","journal-title":"Arthritis Care Res"},{"key":"569_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MD.0000000000000018","volume":"93","author":"MA Alba","year":"2014","unstructured":"Alba MA, Velasco C, Sime\u00f3n CP, et al. Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients. Medicine (Baltimore). 2014;93:73\u201381.","journal-title":"Medicine (Baltimore)."},{"key":"569_CR10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10238-017-0475-0","volume":"18","author":"LA Bautista-Herrera","year":"2018","unstructured":"Bautista-Herrera LA, De la Cruz-Mosso U, Morales-Zambrano R, et al. Expression of MIF and TNFA in psoriatic arthritis: relationship with Th1\/Th2\/Th17 cytokine profiles and clinical variables. Clin Exp Med. 2018;18:229\u201335.","journal-title":"Clin Exp Med"},{"key":"569_CR11","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1517\/17425255.2014.970165","volume":"10","author":"G Murdaca","year":"2014","unstructured":"Murdaca G, Span\u00f2 F, Contatore M, Guastalla A, Magnani O, Puppo F. Pharmacogenetics of etanercept: role of TNF-\u03b1 gene polymorphisms in improving its efficacy. Expert Opin Drug Metab Toxicol. 2014;10:1703\u201310.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"569_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/imt.13.173","volume":"6","author":"G Murdaca","year":"2014","unstructured":"Murdaca G, Span\u00f2 F, Contatore M, Guastalla A, Puppo F. Potential use of TNF-\u03b1 inhibitors in systemic sclerosis. Immunotherapy. 2014;6:283\u20139.","journal-title":"Immunotherapy"},{"key":"569_CR13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.gene.6363793","volume":"2","author":"J Z\u00fa\u00f1iga","year":"2001","unstructured":"Z\u00fa\u00f1iga J, Vargas-Alarc\u00f3n G, Hern\u00e1ndez-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun. 2001;2:363\u20136.","journal-title":"Genes Immun"},{"key":"569_CR14","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1038\/jid.2014.123","volume":"134","author":"G Murdaca","year":"2014","unstructured":"Murdaca G, Gulli R, Span\u00f2 F, Lantieri F, Burlando M, Parodi A, et al. TNF-\u03b1 gene polymorphisms: association with disease susceptibility and response to anti-TNF-\u03b1 treatment in psoriatic arthritis. J Investig Dermatol. 2014;134:2503\u20139.","journal-title":"J Investig Dermatol"},{"key":"569_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.humimm.2014.02.014","volume":"75","author":"U De la Cruz-Mosso","year":"2014","unstructured":"De la Cruz-Mosso U, Bucala R, Palafox-S\u00e1nchez CA, et al. Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-\u03b1 in systemic lupus erythematosus. Hum Immunol. 2014;75:433\u20139.","journal-title":"Hum Immunol"},{"key":"569_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08923973.2015.1017645","volume":"37","author":"LM Brennan-Bourdon","year":"2015","unstructured":"Brennan-Bourdon LM, De la Cruz-Mosso U, Reyes-Castillo Z, et al. MIF and TNF\u03b1 serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study. Immunopharmacol Immunotoxicol. 2015;37:207\u201313.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"569_CR17","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1007\/s00296-011-2157-7","volume":"32","author":"A Moniuszko","year":"2012","unstructured":"Moniuszko A, Gi\u0144dzie\u0144ska-Sie\u015bkiewicz E, Pancewicz SA, Czupryna P, Zajkowska J, Sierakowski S. Evaluation of skin thickness lesions in patients with Lyme disease measured by modified Rodnan total skin score. Rheumatol Int. 2012;32:3189\u201391.","journal-title":"Rheumatol Int"},{"key":"569_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2017.03.016","volume":"153","author":"H De la Corte-Rodriguez","year":"2017","unstructured":"De la Corte-Rodriguez H, Rodriguez-Merchan EC. The health assessment questionnaire disability index (HAQ-DI) as a valid alternative for measuring the functional capacity of people with haemophilia. Thromb Res. 2017;153:51\u20136.","journal-title":"Thromb Res"},{"key":"569_CR19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.","journal-title":"Nucleic Acids Res"},{"key":"569_CR20","first-page":"937","volume":"56","author":"E Oreg\u00f3n-Romero","year":"2008","unstructured":"Oreg\u00f3n-Romero E, V\u00e1zquez-Del Mercado M, Ruiz-Quezada SL, et al. Tumor necrosis factor alpha-308 and -238 polymorphisms in rheumatoid arthritis. Association with messenger RNA expression and sTNF-alpha. J Investig Med Off Publ Am Fed Clin Res. 2008;56:937\u201343.","journal-title":"J Investig Med Off Publ Am Fed Clin Res"},{"key":"569_CR21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1987","unstructured":"Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156\u20139.","journal-title":"Anal Biochem"},{"key":"569_CR22","first-page":"4","volume":"81","author":"RT Alekperov","year":"2003","unstructured":"Alekperov RT, Timchenko AV, Nasonov EL. Tumor necrosis factor alpha in systemic scleroderma. Klin Med (Mosk). 2003;81:4\u20137.","journal-title":"Klin Med (Mosk)."},{"key":"569_CR23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0198-8859(99)00105-6","volume":"60","author":"JP Pandey","year":"1999","unstructured":"Pandey JP, Takeuchi F. TNF-alpha and TNF-beta gene polymorphisms in systemic sclerosis. Hum Immunol. 1999;60:1128\u201330.","journal-title":"Hum Immunol"},{"key":"569_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.imlet.2004.08.002","volume":"96","author":"B Tolusso","year":"2005","unstructured":"Tolusso B, Fabris M, Caporali R, et al. 238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis. Immunol Lett. 2005;96:103\u20138.","journal-title":"Immunol Lett"},{"key":"569_CR25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10528-008-9182-6","volume":"46","author":"O Ates","year":"2008","unstructured":"Ates O, M\u00fcsellim B, Ongen G, Topal-Sarikaya A. Analysis of TNF polymorphisms in Turkish systemic sclerosis patients with interstitial lung involvement. Biochem Genet. 2008;46:696\u2013701.","journal-title":"Biochem Genet"},{"key":"569_CR26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.gde.2010.02.007","volume":"20","author":"CA Haiman","year":"2010","unstructured":"Haiman CA, Stram DO. Exploring genetic susceptibility to cancer in diverse populations. Curr Opin Genet Dev. 2010;20:330\u20135.","journal-title":"Curr Opin Genet Dev"},{"key":"569_CR27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08916934.2017.1357699","volume":"50","author":"C Liaskos","year":"2017","unstructured":"Liaskos C, Marou E, Simopoulou T, et al. Disease-related autoantibody profile in patients with systemic sclerosis. Autoimmunity. 2017;50:414\u201321.","journal-title":"Autoimmunity"},{"key":"569_CR28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/art.20065","volume":"50","author":"H Sato","year":"2004","unstructured":"Sato H, Lagan AL, Alexopoulou C, et al. The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. Arthritis Rheum. 2004;50:558\u201364.","journal-title":"Arthritis Rheum"},{"key":"569_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1242\/jcs.114.1.131","volume":"114","author":"YP Han","year":"2001","unstructured":"Han YP, Tuan TL, Wu H, Hughes M, Garner WL. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci. 2001;114:131\u20139.","journal-title":"J Cell Sci"},{"key":"569_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","volume":"27","author":"S Sato","year":"2001","unstructured":"Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci. 2001;27:140\u20136.","journal-title":"J Dermatol Sci"},{"key":"569_CR31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370.","journal-title":"N Engl J Med"},{"key":"569_CR32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/0019-5154.160477","volume":"60","author":"NN Moorchung","year":"2015","unstructured":"Moorchung NN, Vasudevan B, Chatterjee M, Grewal RS, Mani NS. A comprehensive study of tumor necrosis factor-alpha genetic polymorphisms, its expression in skin and relation to histopathological features in psoriasis. Indian J Dermatol. 2015;60:345\u201350.","journal-title":"Indian J Dermatol"},{"key":"569_CR33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/rheumatology\/41.8.869","volume":"41","author":"V Young","year":"2002","unstructured":"Young V, Ho M, Vosper H, Belch JJF, Palmer CNA. Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leucocytes from patients with systemic sclerosis. Rheumatol Oxf Engl. 2002;41:869\u201375.","journal-title":"Rheumatol Oxf Engl"},{"key":"569_CR34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1756-185X.2012.01755.x","volume":"15","author":"Y Pehlivan","year":"2012","unstructured":"Pehlivan Y, Onat AM, Ceylan N, et al. Serum leptin, resistin and TNF-\u03b1 levels in patients with systemic sclerosis: the role of adipokines in scleroderma. Int J Rheum Dis. 2012;15:374\u20139.","journal-title":"Int J Rheum Dis"},{"key":"569_CR35","doi-asserted-by":"crossref","first-page":"e35408","DOI":"10.1371\/journal.pone.0035408","volume":"7","author":"Y Li","year":"2012","unstructured":"Li Y. Tumor necrosis factor-alpha G308a gene polymorphism and essential hypertension: a meta-analysis involving 2244 participants. PLoS ONE. 2012;7:e35408.","journal-title":"PLoS ONE"},{"key":"569_CR36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejim.2010.01.004","volume":"21","author":"B Faucher","year":"2010","unstructured":"Faucher B, Stein P, Granel B, et al. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma. Eur J Intern Med. 2010;21:114\u20137.","journal-title":"Eur J Intern Med"},{"key":"569_CR37","first-page":"295","volume":"24","author":"S Guerini","year":"2007","unstructured":"Guerini S, Cavazzana I, Venturelli C, et al. Renal involvement in systemic sclerosis. G Ital Nefrol Organo Uff Della Soc Ital Nefrol. 2007;24:295\u2013310.","journal-title":"G Ital Nefrol Organo Uff Della Soc Ital Nefrol"},{"key":"569_CR38","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/ar2821","volume":"11","author":"P Gourh","year":"2009","unstructured":"Gourh P, Arnett FC, Assassi S, et al. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Res Ther. 2009;11:R147.","journal-title":"Arthritis Res Ther"},{"key":"569_CR39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-7-16","volume":"7","author":"K Tanabe","year":"2010","unstructured":"Tanabe K, Matsushima-Nishiwaki R, Yamaguchi S, Iida H, Dohi S, Kozawa O. Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells. J Neuroinflamm. 2010;7:16.","journal-title":"J Neuroinflamm"},{"key":"569_CR40","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood-2009-07-230631","volume":"115","author":"K Maeda","year":"2010","unstructured":"Maeda K, Mehta H, Drevets DA, Coggeshall KM. IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production. Blood. 2010;115:4699\u2013706.","journal-title":"Blood"},{"key":"569_CR41","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295.","journal-title":"Cold Spring Harb Perspect Biol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00569-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-019-00569-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00569-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T19:16:37Z","timestamp":1664046997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-019-00569-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1007\/s10238-019-00569-4","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"22 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Local Bioethical Committee at the Hospital General de Chilpancingo \u201cDr. Raymundo Abarca Alarc\u00f3n\u201d and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}